HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
June 28, 2022 15:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors With Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
June 14, 2022 16:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
June 08, 2022 16:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors With Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
June 02, 2022 09:31 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is...